Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Nutritional intervention in patients with hypopituitarism secondary to pituitary adenomas with metabolic syndrome

Authors: Renata Elisabeth Rothen, Bruna Breyer de Freitas, Carolina Garcia Soares Leães, Miriam da Costa Oliveira, Fernanda Michielin Busnello, Júlia Fernanda Semmelmann Pereira-Lima

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

The deficiency in the production of any of the pituitary hormones, denominated hypopituitarism, may cause the increase of visceral fat, dyslipidemia and decrease of muscle mass. Metabolic syndrome (MetS) is a complex disorder, characterized by alterations of the lipid profile, abdominal obesity, blood pressure and insulin resistance, being highly prevalent in hypopituitarism. …
Metadata
Title
Nutritional intervention in patients with hypopituitarism secondary to pituitary adenomas with metabolic syndrome
Authors
Renata Elisabeth Rothen
Bruna Breyer de Freitas
Carolina Garcia Soares Leães
Miriam da Costa Oliveira
Fernanda Michielin Busnello
Júlia Fernanda Semmelmann Pereira-Lima
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A118

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine